Therapy Areas: Diabetes
Hangzhou Sciwind Biosciences' XW003 clinical trial receives Chinese regulatory approval
1 March 2021 - Hangzhou Sciwind Biosciences Co Ltd, a clinical-stage biotech company focusing on research and development of innovative biologics, announced on Sunday that it has received approval for...
Jaguar Gene Therapy Launches with Goal of Accelerating Breakthroughs in Gene Therapy for Patients Suffering from Severe Genetic Diseases
25 February 2021 - - US-based gene therapies developer Jaguar Gene Therapy has launched after being in stealth mode for the past year and is uniquely positioned to accelerate gene therapy develop...
First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States
23 February 2021 - - The first healthy adult volunteer has been safely dosed in the phase I study of LG00303174 being run in the US, South Korea-based LG Chem Life Sciences said.

LG Chem ...
Abbott announces 389th consecutive dividend of USD0.45 per share for quarter
22 February 2021 - Abbott Laboratories (NYSE:ABT) reported on Friday that its board of directors authorised a common stock dividend of USD0.45 per share for the quarter, the company .This 389th consec...
Abbott announces 389th consecutive dividend of USD0.45 per share for quarter
22 February 2021 - Abbott Laboratories (NYSE:ABT) reported on Friday that its board of directors authorised a common stock dividend of USD0.45 per share for the quarter, the company .This 389th consec...
TIKOMED reports start of Phase II study with IBSOLVMIR
12 February 2021 - Swedish pharmaceutical company TIKOMED AB reported on Friday that the first patient has been treated in its Phase II study of clinical islet transplantation in patients with brittle...
Related Headlines

FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older

Integral Molecular Enables Rapid Resistance Testing of Vaccines and Drugs Against Emerging Coronavirus Variants

Celltrion's COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation

Vertex Wins FDA Clearance of Investigational New Drug Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of EUR 35m

Volunteer in Sinopharm's COVID-19 vaccine trial in Peru dies of COVID-19 pneumonia

Genentech's Faricimab Meets Primary Endpoint in Two Global Phase III Studies

US FDA Accepts New Drug Application and Grants Priority Review for Bayer Investigational Drug Finerenone for Patients with Chronic Kidney Disease and Type 2 Diabetes

Follicum awarded European patent for potential diabetes therapy

Aerie Pharmaceuticals Receives European Commission Approval for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%

REMD Biotherapeutics Completes Enrollment, Posts Top-line Results of a Phase 2 Clinical Study of Volagidemab (REMD-477) in Patients with Type 1 Diabetes

Inversago Pharma Receives Rare Pediatric Disease Designation from the FDA for INV-101 for the Treatment of Prader-Willi Syndrome

Jnana Therapeutics Names Chen to Board of Directors, Susztak to Scientific Advisory Board

AstraZeneca's Farxiga granted FDA Priority Review for treatment of chronic kidney disease

Colombia approves Pfizer-BioNTech COVID-19 vaccine for emergency use